
Randall L. Beane
Examiner (ID: 7309, Phone: (571)270-3457 , Office: P/1675 )
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1675, 1654 |
| Total Applications | 588 |
| Issued Applications | 169 |
| Pending Applications | 127 |
| Abandoned Applications | 335 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18953736
[patent_doc_number] => 20240042063
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => LINKED AND OTHER pH-TRIGGERED COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 18/331904
[patent_app_country] => US
[patent_app_date] => 2023-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57180
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18331904
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/331904 | LINKED AND OTHER pH-TRIGGERED COMPOUNDS | Jun 7, 2023 | Abandoned |
Array
(
[id] => 19003624
[patent_doc_number] => 20240067695
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-29
[patent_title] => GLUCAGON-LIKE PEPTIDE-2 COMPOSITIONS AND METHODS OF MAKING AND USING SAME
[patent_app_type] => utility
[patent_app_number] => 18/330032
[patent_app_country] => US
[patent_app_date] => 2023-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 81624
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18330032
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/330032 | GLUCAGON-LIKE PEPTIDE-2 COMPOSITIONS AND METHODS OF MAKING AND USING SAME | Jun 5, 2023 | Abandoned |
Array
(
[id] => 18725795
[patent_doc_number] => 20230340013
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => POLYPEPTIDES AND METHODS
[patent_app_type] => utility
[patent_app_number] => 18/198205
[patent_app_country] => US
[patent_app_date] => 2023-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17868
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18198205
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/198205 | POLYPEPTIDES AND METHODS | May 15, 2023 | Abandoned |
Array
(
[id] => 18725795
[patent_doc_number] => 20230340013
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => POLYPEPTIDES AND METHODS
[patent_app_type] => utility
[patent_app_number] => 18/198205
[patent_app_country] => US
[patent_app_date] => 2023-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17868
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18198205
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/198205 | POLYPEPTIDES AND METHODS | May 15, 2023 | Abandoned |
Array
(
[id] => 18725795
[patent_doc_number] => 20230340013
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => POLYPEPTIDES AND METHODS
[patent_app_type] => utility
[patent_app_number] => 18/198205
[patent_app_country] => US
[patent_app_date] => 2023-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17868
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18198205
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/198205 | POLYPEPTIDES AND METHODS | May 15, 2023 | Abandoned |
Array
(
[id] => 18939615
[patent_doc_number] => 20240034754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-01
[patent_title] => ENZYMATIC BIOCIDE FOR REMOVAL OF FOODBORNE MICROBIAL CONTAMINATION
[patent_app_type] => utility
[patent_app_number] => 18/314035
[patent_app_country] => US
[patent_app_date] => 2023-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24830
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18314035
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/314035 | ENZYMATIC BIOCIDE FOR REMOVAL OF FOODBORNE MICROBIAL CONTAMINATION | May 7, 2023 | Pending |
Array
(
[id] => 18709183
[patent_doc_number] => 20230331795
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => ENGINEERING IMMUNE CHECKPOINT BLOCKADE NANOBODY-STING DELTA-TM FUSION PROTEIN AS A VERSATILE TREATMENT FOR SOLID TUMOR CANCERS
[patent_app_type] => utility
[patent_app_number] => 18/312030
[patent_app_country] => US
[patent_app_date] => 2023-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15032
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18312030
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/312030 | ENGINEERING IMMUNE CHECKPOINT BLOCKADE NANOBODY-STING DELTA-TM FUSION PROTEIN AS A VERSATILE TREATMENT FOR SOLID TUMOR CANCERS | May 3, 2023 | Pending |
Array
(
[id] => 18709183
[patent_doc_number] => 20230331795
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => ENGINEERING IMMUNE CHECKPOINT BLOCKADE NANOBODY-STING DELTA-TM FUSION PROTEIN AS A VERSATILE TREATMENT FOR SOLID TUMOR CANCERS
[patent_app_type] => utility
[patent_app_number] => 18/312030
[patent_app_country] => US
[patent_app_date] => 2023-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15032
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18312030
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/312030 | ENGINEERING IMMUNE CHECKPOINT BLOCKADE NANOBODY-STING DELTA-TM FUSION PROTEIN AS A VERSATILE TREATMENT FOR SOLID TUMOR CANCERS | May 3, 2023 | Pending |
Array
(
[id] => 18692632
[patent_doc_number] => 20230322951
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => Bi-Specific Fusion Proteins
[patent_app_type] => utility
[patent_app_number] => 18/311306
[patent_app_country] => US
[patent_app_date] => 2023-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14077
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18311306
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/311306 | Bi-Specific Fusion Proteins | May 2, 2023 | Pending |
Array
(
[id] => 19418451
[patent_doc_number] => 20240294574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-05
[patent_title] => STABILIZED PEPTIDES FOR COVALENT BINDING TO TARGET PROTEIN
[patent_app_type] => utility
[patent_app_number] => 18/306724
[patent_app_country] => US
[patent_app_date] => 2023-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24679
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18306724
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/306724 | STABILIZED PEPTIDES FOR COVALENT BINDING TO TARGET PROTEIN | Apr 24, 2023 | Pending |
Array
(
[id] => 18879071
[patent_doc_number] => 20240002440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS, INFLAMMATION, CANCER AND OTHER DISORDERS
[patent_app_type] => utility
[patent_app_number] => 18/186292
[patent_app_country] => US
[patent_app_date] => 2023-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31314
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18186292
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/186292 | AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS, INFLAMMATION, CANCER AND OTHER DISORDERS | Mar 19, 2023 | Pending |
Array
(
[id] => 19049346
[patent_doc_number] => 20240091315
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => XTEN CONJUGATE COMPOSITIONS AND METHODS OF MAKING SAME
[patent_app_type] => utility
[patent_app_number] => 18/182954
[patent_app_country] => US
[patent_app_date] => 2023-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 135764
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18182954
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/182954 | XTEN CONJUGATE COMPOSITIONS AND METHODS OF MAKING SAME | Mar 12, 2023 | Pending |
Array
(
[id] => 18737852
[patent_doc_number] => 20230346752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING
[patent_app_type] => utility
[patent_app_number] => 18/181487
[patent_app_country] => US
[patent_app_date] => 2023-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22191
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18181487
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/181487 | PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING | Mar 8, 2023 | Pending |
Array
(
[id] => 18567099
[patent_doc_number] => 20230257428
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => METHODS OF TREATMENT USING CHLOROTOXIN CONJUGATES
[patent_app_type] => utility
[patent_app_number] => 18/160954
[patent_app_country] => US
[patent_app_date] => 2023-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 63182
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 262
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18160954
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/160954 | METHODS OF TREATMENT USING CHLOROTOXIN CONJUGATES | Jan 26, 2023 | Abandoned |
Array
(
[id] => 18567099
[patent_doc_number] => 20230257428
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => METHODS OF TREATMENT USING CHLOROTOXIN CONJUGATES
[patent_app_type] => utility
[patent_app_number] => 18/160954
[patent_app_country] => US
[patent_app_date] => 2023-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 63182
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 262
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18160954
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/160954 | METHODS OF TREATMENT USING CHLOROTOXIN CONJUGATES | Jan 26, 2023 | Abandoned |
Array
(
[id] => 18374435
[patent_doc_number] => 20230149514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => CROSSLINKED PARTICLES, COMPOSITION COMPRISING THE CROSSLINKED PARTICLES, METHOD FOR THE MANUFACTURE THEREOF, AND METHOD OF TREATING AN INFECTION
[patent_app_type] => utility
[patent_app_number] => 18/099378
[patent_app_country] => US
[patent_app_date] => 2023-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8122
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18099378
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/099378 | CROSSLINKED PARTICLES, COMPOSITION COMPRISING THE CROSSLINKED PARTICLES, METHOD FOR THE MANUFACTURE THEREOF, AND METHOD OF TREATING AN INFECTION | Jan 19, 2023 | Abandoned |
Array
(
[id] => 18970442
[patent_doc_number] => 20240050534
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => USE OF COLLAGEN COMPOSITIONS FOR INCREASING TELOMERE LENGTH
[patent_app_type] => utility
[patent_app_number] => 18/096941
[patent_app_country] => US
[patent_app_date] => 2023-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9518
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18096941
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/096941 | USE OF COLLAGEN COMPOSITIONS FOR INCREASING TELOMERE LENGTH | Jan 12, 2023 | Abandoned |
Array
(
[id] => 18970442
[patent_doc_number] => 20240050534
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => USE OF COLLAGEN COMPOSITIONS FOR INCREASING TELOMERE LENGTH
[patent_app_type] => utility
[patent_app_number] => 18/096941
[patent_app_country] => US
[patent_app_date] => 2023-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9518
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18096941
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/096941 | USE OF COLLAGEN COMPOSITIONS FOR INCREASING TELOMERE LENGTH | Jan 12, 2023 | Abandoned |
Array
(
[id] => 18366686
[patent_doc_number] => 20230148277
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => DISULFIDE BOND CONTAINING COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/093509
[patent_app_country] => US
[patent_app_date] => 2023-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17619
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18093509
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/093509 | DISULFIDE BOND CONTAINING COMPOUNDS AND USES THEREOF | Jan 4, 2023 | Abandoned |
Array
(
[id] => 18716538
[patent_doc_number] => 11793861
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-24
[patent_title] => PTH prodrugs
[patent_app_type] => utility
[patent_app_number] => 18/053693
[patent_app_country] => US
[patent_app_date] => 2022-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34961
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18053693
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/053693 | PTH prodrugs | Nov 7, 2022 | Issued |